1
|
Watkins LV, Dunstall H, Musicha C, Lawthom C, John K, Bright C, Richings C, Harding K, Moon S, Pape SE, Winterhalder R, Allgar V, Thomas RH, McLean B, Laugharne R, Shankar R. Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study. J Neurol 2023; 270:5889-5902. [PMID: 37610448 DOI: 10.1007/s00415-023-11959-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 08/17/2023] [Accepted: 08/18/2023] [Indexed: 08/24/2023]
Abstract
BACKGROUND Approximately one quarter of people with an intellectual disability (PwID) have epilepsy of whom nearly three-quarters are pharmaco-resistant. There are higher reported neuropsychiatric side-effects to anti-seizure medication (ASM) in this group. Levetiracetam (LEV) is a first-line ASM with a stronger association with neuropsychiatric symptoms for PwID than other ASMs. Brivaracetam (BRV) is a newer ASM. Recent studies suggest a beneficial effect of swapping people who experience neuropsychiatric events with LEV to BRV. However, there is limited evidence of this for PwID. This evaluation analyses real world outcomes of LEV to BRV swap for PwID compared to those without ID. METHODS We performed a multicentre, retrospective review of clinical records. Demographic, clinical characteristics and reported adverse events of patients switched from LEV to BRV (2016-2020) were recorded at 3 months pre and 6- and 12-month post-BRV initiation. Outcomes were compared between PwID and those without and summarised using cross-tabulations and logistic regression models. A Bonferroni correction was applied. RESULTS Of 77 participants, 46 had ID and 52% had a past psychiatric illness. 71% participants switched overnight from LEV to BRV. Seizure reduction of > 50% was seen in 40% patients. Psychiatric illness history was predictive of having neuropsychiatric side-effects with LEV but not BRV (p = 0.001). There was no significant difference for any primary outcomes between PwID versus without ID. CONCLUSIONS Switching from LEV to BRV appears as well tolerated and efficacious in PwID as those without ID with over 90% still on BRV after 12 months.
Collapse
Affiliation(s)
- L V Watkins
- Swansea Bay University Health Board, Port Talbot, UK
- University of South Wales, Aberdare, UK
- University of Plymouth, Plymouth, UK
| | - H Dunstall
- Swansea Bay University Health Board, Port Talbot, UK
| | - C Musicha
- University of Plymouth, Plymouth, UK
| | - C Lawthom
- Aneurin Bevan University Health Board, Newport, UK
- Swansea University, Swansea, UK
| | - K John
- Aneurin Bevan University Health Board, Newport, UK
| | - C Bright
- University of South Wales, Aberdare, UK
- Aneurin Bevan University Health Board, Newport, UK
| | - C Richings
- Aneurin Bevan University Health Board, Newport, UK
| | - K Harding
- Aneurin Bevan University Health Board, Newport, UK
| | - S Moon
- Swansea Bay University Health Board, Port Talbot, UK
| | - S E Pape
- Oxleas NHS Foundation Trust, Kent, UK
| | | | - V Allgar
- University of Plymouth, Plymouth, UK
| | - R H Thomas
- Newcastle University, Newcastle upon Tyne, UK
- The Newcastle Upon Tyne Hospital NHS Foundation Trust, Newcastle upon Tyne, UK
| | - B McLean
- University of Plymouth, Plymouth, UK
| | | | - Rohit Shankar
- University of Plymouth, Plymouth, UK.
- Cornwall Partnership NHS Foundation Trust, Threemilestone Industrial Estate, Truro, TR4 9LD, UK.
| |
Collapse
|
2
|
Lee Y, Moon S, Seok JY, Lee JH, Nam S, Chung YS. Characterization of the genomic alterations in poorly differentiated thyroid cancer. Sci Rep 2023; 13:19154. [PMID: 37932340 PMCID: PMC10628257 DOI: 10.1038/s41598-023-46466-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 11/01/2023] [Indexed: 11/08/2023] Open
Abstract
Poorly differentiated thyroid carcinoma (PDTC) is a subtype of thyroid cancer that has a high rate of metastasis or recurrence and a relatively poor prognosis. However, there are few studies that have been conducted on PDTC at the whole protein-coding gene scale. Here, we performed genomic profiling of 15 patients with PDTC originated from follicular thyroid carcinoma using whole exome sequencing and also performed gene functional enrichment analysis of differentially expressed genes (DEGs) for three patients. Further, we investigated genetic variants associated with PDTC progression and the characteristics of clinical pathology. We revealed somatic genomic alterations in the RAF1, MAP2K2, and AKT2 genes that were not reported in previous studies. We confirmed frequent occurrences in the RAS gene in patients with PDTC; the genetic alterations were associated with the RAS-RAF-MEK-ERK/JNK, PI3K-AKT-mTOR signaling pathways, and the cell cycle. DEG analysis showed that immune response was lower in cancer tissues than in normal tissues. Through the association analysis of somatic mutations and the characteristics of clinical pathology from patients with PDTC, the somatic mutations of ABCA12, CLIP1, and ATP13A3 were significantly associated with a vascular invasion phenotype. By providing molecular genetic insight on PDTC, this study may contribute to the discovery of novel therapeutic target candidates.
Collapse
Affiliation(s)
- Yeeun Lee
- Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Dokjeom-ro 3Beon-gil, 38-13, Namdong-gu, Incheon, 21565, Republic of Korea
| | - SeongRyeol Moon
- A.I. Structural Design Team, Division of Biodrug Analysis, New Drug Development Center, OSONG Medical Innovation Foundation, Cheongju-si, 28160, Chungcheongbuk-do, Korea
| | - Jae Yeon Seok
- Department of Pathology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin Severance Hospital 363, Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Korea
| | - Joon-Hyop Lee
- Department of Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine, Dokjeom-ro 3Beon-gil, 38-13, Namdong-gu, Incheon, 21565, Republic of Korea
| | - Seungyoon Nam
- Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Dokjeom-ro 3Beon-gil, 38-13, Namdong-gu, Incheon, 21565, Republic of Korea.
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon, 21999, Korea.
| | - Yoo Seung Chung
- Department of Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine, Dokjeom-ro 3Beon-gil, 38-13, Namdong-gu, Incheon, 21565, Republic of Korea.
| |
Collapse
|
3
|
Bae S, Jang J, Kook Y, Baek S, Kim J, Kim M, Lee S, Moon S, Kim J, Ahn S, Jeong J. P118 Efficacy of platinum-based neoadjuvant chemotherapy in early triple-negative breast cancer according to germline BRCA mutation. Breast 2023. [DOI: 10.1016/s0960-9776(23)00235-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/15/2023] Open
|
4
|
Jang J, Kook Y, Baek S, Kim J, Kim M, Lee S, Moon S, Kim J, Bae S, Ahn S, Jeong J. P217 Upstaging and lymph node metastasis rate in patients with ductal carcinoma in situ who received mastectomy regarding the necessary of sentinel lymph node biopsy. Breast 2023. [DOI: 10.1016/s0960-9776(23)00335-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
|
5
|
Moon S, Kim HJ, Lee Y, Lee YJ, Jung S, Lee JS, Hahn SH, Kim K, Roh JY, Nam S. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma. Comput Biol Med 2023; 154:106602. [PMID: 36716688 DOI: 10.1016/j.compbiomed.2023.106602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 12/23/2022] [Accepted: 01/22/2023] [Indexed: 01/25/2023]
Abstract
Acral melanoma (AM), a rare subtype of cutaneous melanoma, shows higher incidence in Asians, including Koreans, than in Caucasians. However, the genetic modification associated with AM in Koreans is not well known and has not been comprehensively investigated in terms of oncogenic signaling, and hallmarks of cancer. We performed whole-exome and RNA sequencing for Korean patients with AM and acquired the genetic alterations and gene expression profiles. KIT alterations (previously known to be recurrent alterations in AM) and CDK4/CCND1 copy number amplifications were identified in the patients. Genetic and transcriptomic alterations in patients with AM were functionally converge to the hallmarks of cancer and oncogenic pathways, including 'proliferative signal persistence', 'apoptotic resistance', and 'activation of invasion and metastasis', despite the heterogeneous somatic mutation profiles of Korean patients with AM. This study may provide a molecular understanding for therapeutic strategy for AM.
Collapse
Affiliation(s)
- SeongRyeol Moon
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, 21999, South Korea
| | - Hee Joo Kim
- Department of Dermatology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea
| | - Yeeun Lee
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, 21999, South Korea
| | - Yu Joo Lee
- Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea
| | - Sungwon Jung
- Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea
| | - Jin Sook Lee
- Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea; Department of Pediatrics, Seoul National University Hospital Child Cancer and Rare Disease Administration, Seoul National University Children's Hospital, Seoul, 03080, South Korea
| | - Si Houn Hahn
- Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, 98105, USA
| | | | - Joo Young Roh
- Department of Dermatology, Ewha Womans University College of Medicine, Seoul Hospital, Seoul, 07804, South Korea.
| | - Seungyoon Nam
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, 21999, South Korea; Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, South Korea; AI Convergence Center for Medical Science, Gachon University College of Medicine, Incheon, 21565, South Korea.
| |
Collapse
|
6
|
Han K, Kim S, Liaw V, Kim M, Kwon J, Moon S, Kim G, Won J, Park J, Kim H. Abstract No. 145 Resorbable Gelatin Microspheres versus Tris-Acryl Microspheres: Randomized Controlled Trial Comparing Pain, Inflammatory Response and Embolic Effect after Uterine Artery Embolization for Symptomatic Fibroids. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
|
7
|
Kim J, Park JH, Moon S, Kim S, Song J, Ahn S, Cho H. 46 The Effect of Mechanical Chest Compression Device on Survival After Out-of-Hospital Cardiac Arrest According to Patient Transport Interval: A Multi-center Observational Study. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
8
|
Song J, Kim SJ, Lee S, Lim H, Ahn S, Kim J, Park J, Cho HJ, Moon S, Jeon ET. 44 Prediction of Mortality Among Patients With Isolated Traumatic Brain Injury Using Machine Learning Models in Asian Countries: An International Multicenter Cohort Study. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
9
|
Jin BY, Song J, Kim J, Park JH, Kim S, Cho H, Moon S, Kim DH, Ahn S. 127 Effect of Metformin on Survival Outcomes in In-Hospital Cardiac Arrest Patients With Diabetes. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
10
|
Park KW, Kim J, Seo J, Moon S, Jeong K, An K. Entropic comparison of Landau-Zener and Demkov interactions in the phase space of a quadrupole billiard. Chaos 2022; 32:103101. [PMID: 36319274 DOI: 10.1063/5.0101495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 09/05/2022] [Indexed: 06/16/2023]
Abstract
We investigate two types of avoided crossings in a chaotic billiard within the framework of information theory. The Shannon entropy in the phase space for the Landau-Zener interaction increases as the center of the avoided crossing is approached, whereas for the Demkov interaction, the Shannon entropy decreases as the center of avoided crossing is passed by with an increase in the deformation parameter. This feature can provide a new indicator for scar formation. In addition, it is found that the Fisher information of the Landau-Zener interaction is significantly larger than that of the Demkov interaction.
Collapse
Affiliation(s)
- K-W Park
- Research Institute of Mathematics, Seoul National University, Seoul 08826, South Korea
| | - J Kim
- Department of Physics and Astronomy and Institute of Applied Physics, Seoul National University, Seoul 08826, South Korea
| | - J Seo
- Department of Physics and Astronomy and Institute of Applied Physics, Seoul National University, Seoul 08826, South Korea
| | - S Moon
- Faculty of Liberal Education, Seoul National University, Seoul 08826, South Korea
| | - K Jeong
- Research Institute of Mathematics, Seoul National University, Seoul 08826, South Korea
| | - K An
- Department of Physics and Astronomy and Institute of Applied Physics, Seoul National University, Seoul 08826, South Korea
| |
Collapse
|
11
|
Choi M, Moon S, Eom HJ, Lim SM, Kim YH, Nam S. High Expression of PRNP Predicts Poor Prognosis in Korean Patients with Gastric Cancer. Cancers (Basel) 2022; 14:cancers14133173. [PMID: 35804944 PMCID: PMC9264980 DOI: 10.3390/cancers14133173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Revised: 06/19/2022] [Accepted: 06/27/2022] [Indexed: 11/16/2022] Open
Abstract
Gastric cancer (GC) has the highest occurrence and fourth-highest mortality rate of all cancers in Korea. Although survival rates are improving with the development of diagnosis and treatment methods, the five-year survival rate for stage 4 GC in Korea remains <10%. Therefore, it is important to identify candidate prognostic factors for predicting poor prognosis. PRNP is a gene encoding the prion protein PrP, which has been noted for its role in the nervous system and is known to be upregulated in various cancers and associated with both cell proliferation and metastasis. However, the value of PRNP as a prognostic factor for Korean GC patients remains unclear. Here, we analyzed the relationship between PRNP expression and survival in three independent datasets for Korean patients with GC as well as the TCGA-STAD dataset. Survival analysis indicates that high levels of PRNP expression are associated with poor overall survival of patients with GC. Gene set enrichment analysis showed that PRNP is associated with epithelial mesenchymal transition and Hedgehog signaling. In addition, proliferation of GC cell lines was inhibited after siRNA-mediated knockdown of PRNP. In conclusion, our study suggests a potential role for PRNP as a candidate prognostic factor for patients with GC.
Collapse
Affiliation(s)
- Minseok Choi
- College of Medicine, Gachon University, Incheon 21565, Korea;
| | - SeongRyeol Moon
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon 21999, Korea;
- Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Korea
| | - Hyo Jin Eom
- Research and Development Department, Corestem Inc., Seongnam 13486, Korea;
| | - Seung Mook Lim
- Department of Biomedical Science, CHA University, Seongnam 13486, Korea;
| | | | - Seungyoon Nam
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon 21999, Korea;
- Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Korea
- Correspondence: ; Tel.: +82-32-458-2737; Fax: +82-32-458-2875
| |
Collapse
|
12
|
Cho S, Moon S, Park S, Sahyun P, Kwon O, Lee Y. Nocturia as a risk factor of all-cause and cardiovascular disease mortality: Data from the national health and nutrition examination survey. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00919-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Behrouzi R, Moon S, Eaton D. 327P Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
14
|
Moon M, Shin J, Choi K, Kang J, Rim G, Jo H, Moon S. P62.01 3D Cell Model Development for Optimizing Intrapleural Hyperthermic Chemotherapy in Advanced Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
15
|
Goriaev A, Wauters T, Möller S, Brakel R, Brezinsek S, Buermans J, Crombé K, Dinklage A, Habrichs R, Höschen D, Krause M, Kovtun Y, López-Rodríguez D, Louche F, Moon S, Nicolai D, Thomas J, Ragona R, Rubel M, Rüttgers T, Petersson P, Brunsell P, Linsmeier C, Van Schoor M. The upgraded TOMAS device: A toroidal plasma facility for wall conditioning, plasma production, and plasma-surface interaction studies. Rev Sci Instrum 2021; 92:023506. [PMID: 33648119 DOI: 10.1063/5.0033229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 01/12/2021] [Indexed: 06/12/2023]
Abstract
The Toroidal Magnetized System device has been significantly upgraded to enable development of various wall conditioning techniques, including methods based on ion and electron cyclotron (IC/EC) range of frequency plasmas, and to complement plasma-wall interaction research in tokamaks and stellarators. The toroidal magnetic field generated by 16 coils can reach its maximum of 125 mT on the toroidal axis. The EC system is operated at 2.45 GHz with up to 6 kW forward power. The IC system can couple up to 6 kW in the frequency range of 10 MHz-50 MHz. The direct current glow discharge system is based on a graphite anode with a maximum voltage of 1.5 kV and a current of 6 A. A load-lock system with a vertical manipulator allows exposure of material samples. A number of diagnostics have been installed: single- and triple-pin Langmuir probes for radial plasma profiles, a time-of-flight neutral particle analyzer capable of detecting neutrals in the energy range of 10 eV-1000 eV, and a quadrupole mass spectrometer and video systems for plasma imaging. The majority of systems and diagnostics are controlled by the Siemens SIMATIC S7 system, which also provides safety interlocks.
Collapse
Affiliation(s)
- A Goriaev
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - T Wauters
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - S Möller
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - R Brakel
- Max-Planck-Institute for Plasma Physics, Greifswald, Germany
| | - S Brezinsek
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - J Buermans
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - K Crombé
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - A Dinklage
- Max-Planck-Institute for Plasma Physics, Greifswald, Germany
| | - R Habrichs
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - D Höschen
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - M Krause
- Max-Planck-Institute for Plasma Physics, Greifswald, Germany
| | - Yu Kovtun
- Institute of Plasma Physics, NSC KIPT, Kharkov, Ukraine
| | | | - F Louche
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - S Moon
- Royal Institute of Technology (KTH), Stockholm, Sweden
| | - D Nicolai
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - J Thomas
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - R Ragona
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| | - M Rubel
- Royal Institute of Technology (KTH), Stockholm, Sweden
| | - T Rüttgers
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - P Petersson
- Royal Institute of Technology (KTH), Stockholm, Sweden
| | - P Brunsell
- Royal Institute of Technology (KTH), Stockholm, Sweden
| | - Ch Linsmeier
- Institute for Energy and Climate Research-Plasma Physics, Forschungszentrum Jülich GmbH, Jülich, Germany
| | - M Van Schoor
- Laboratory for Plasma Physics, LPP-ERM/KMS, Trilateral Euregio Cluster (TEC) Partner, Brussels, Belgium
| |
Collapse
|
16
|
Dewaswala-Bhopalwala N, Chen D, Bhopalwala H, Hossein Pour S, Moon S, Bos D, Scott C, Geske J, Noseworthy P, Ommen S, Erickson B, Araoz P, Nishimura R, Ackerman M, Arruda-Olson A. Extracting hypertrophic cardiomyopathy features from cardiac magnetic resonance reports by natural language processing. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
Determine if information regarding hypertrophic cardiomyopathy (HCM) can be accurately retrieved from cardiac magnetic resonance (CMR) reports using natural language processing (NLP).
Background
CMR imaging is used for diagnosis and risk stratification of HCM. Manual annotation of information from CMR is time-consuming. NLP is an artificial intelligence method for automating extraction of information from narrative text.
Methods
We identified 200 HCM patients who had CMR reports from 1998 to 2018. These patients were randomly allocated into training (100 patients with 185 CMR reports) and testing sets (100 patients with 206 reports). An NLP system with 2 tiers was developed; the first extracted information regarding HCM diagnosis while second extracted categorical or numeric concepts for HCM classification. NLP performance was compared with gold-standard manual annotation.
Results
NLP algorithms achieved very high performance across all concepts with mean positive predictive value (PPV) = 0.96. An outlier was the performance for abstracting the presence of an apical pouch from CMR reports, which had noticeably lower PPV= 0.78 which be attributed to the low number of cases with this finding.
Conclusions
The algorithms developed can be translated to clinical decision support systems to increase efficiency and contribute to improved quality of care.
Funding Acknowledgement
Type of funding source: Other. Main funding source(s): Study supported by the National Heart, Lung and Blood Institute of National Institutes of Health (K01HL124045), the Mayo Clinic Center for Clinical and Translational Science (CCaTS), and the Mayo Clinic K2R award. Content is solely the responsibility of authors and does not necessarily represent official views of the National Institutes of Health.
Collapse
Affiliation(s)
| | - D Chen
- Mayo Clinic, Rochester, United States of America
| | - H Bhopalwala
- Mayo Clinic, Rochester, United States of America
| | | | - S Moon
- Mayo Clinic, Rochester, United States of America
| | - D Bos
- Mayo Clinic, Rochester, United States of America
| | - C Scott
- Mayo Clinic, Rochester, United States of America
| | - J Geske
- Mayo Clinic, Rochester, United States of America
| | - P Noseworthy
- Mayo Clinic, Rochester, United States of America
| | - S.R Ommen
- Mayo Clinic, Rochester, United States of America
| | - B.J Erickson
- Mayo Clinic, Rochester, United States of America
| | - P.A Araoz
- Mayo Clinic, Rochester, United States of America
| | | | - M.J Ackerman
- Mayo Clinic, Rochester, United States of America
| | | |
Collapse
|
17
|
Hu Y, St John M, Pellionisz P, Moon S, Alhiyari Y. Method for motion artifact compensation in dynamic optical contrast imaging. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2019.11.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Seok H, Song J, Jeon JH, Choi HK, Choi WS, Moon S, Park DW. Timing of antibiotics in septic patients: a prospective cohort study. Clin Microbiol Infect 2020; 26:1495-1500. [PMID: 32062049 DOI: 10.1016/j.cmi.2020.01.037] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2019] [Revised: 01/30/2020] [Accepted: 01/31/2020] [Indexed: 12/24/2022]
Abstract
OBJECTIVES To evaluate the effect of timing and appropriateness of antibiotics administration on mortality in patients diagnosed with sepsis according to the Sepsis-3 definition. METHODS This prospective cohort study was conducted in patients diagnosed with sepsis according to the Sepsis-3 definition at the emergency department of Korea University Ansan Hospital from January 2016 to January 2019. The time to antibiotics was defined as the time in hours from emergency department arrival to the first antibiotic administration. Cox proportional hazards regression analysis was used to estimate the association between time to antibiotics and 7-, 14- and 28-day mortality. RESULTS Of 482 patients enrolled onto this study, 203 (42.1%) of 482 and 312 (64.7%) of 482 were diagnosed with septic shock and high-grade infection respectively. The median time to receipt of antibiotic therapy was 115 minutes. Antibiotics were administered within 3 and 6 hours in 340 (70.4%) of 482 and 450 (93.2%) of 482 patients respectively. Initial appropriate empirical antibiotics were administered in 375 (77.8%) of 482 patients. The time to and appropriateness of the initial antibiotics were not associated with 7-, 14- and 28-day mortality in multivariate analysis. The Sequential Organ Failure Assessment (SOFA) score (adjusted hazard ratio (aHR) 1.229, 95% confidence interval (CI) 1.093-1.381, p 0.001) and initial lactate levels (aHR 1.128, 95% CI 1.034-1.230, p 0.007), Charlson comorbidity index (aHR 1.115, 95% CI 1.027-1.210, p 0.014), 2-hour lactate level (aHR 1.115, 95% CI 1.027-1.210, p 0.009) and SOFA score (aHR 1.077, 95% CI 1.013-1.144, p 0.018) affected 7-, 14- and 28-day mortality respectively. Subgroup analysis with septic shock, bacteraemia and high-grade infection did not affect mortality rates. CONCLUSIONS Time to receipt of antibiotics may not affect the prognosis of patients with sepsis if a rapid and well-trained resuscitation is combined with appropriate antibiotic administration within a reasonable time.
Collapse
Affiliation(s)
- H Seok
- Division of Infectious Diseases, Department of Medicine, Republic of Korea
| | - J Song
- Department of Emergency Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea
| | - J H Jeon
- Division of Infectious Diseases, Department of Medicine, Republic of Korea
| | - H K Choi
- Division of Infectious Diseases, Department of Medicine, Republic of Korea
| | - W S Choi
- Division of Infectious Diseases, Department of Medicine, Republic of Korea
| | - S Moon
- Department of Emergency Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea
| | - D W Park
- Division of Infectious Diseases, Department of Medicine, Republic of Korea.
| |
Collapse
|
19
|
Moon S, Nam S, Oh J. Linear programming-based prediction of immune cell composition. INT J DATA MIN BIOIN 2020. [DOI: 10.1504/ijdmb.2020.10029557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
20
|
Moon S, Oh J, Nam S. Linear programming-based prediction of immune cell composition. INT J DATA MIN BIOIN 2020. [DOI: 10.1504/ijdmb.2020.107382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
21
|
Park S, Moon S, Lee K, Park IB, Lee DH, Nam S. miR2Diabetes: A Literature-Curated Database of microRNA Expression Patterns, in Diabetic Microvascular Complications. Genes (Basel) 2019; 10:genes10100784. [PMID: 31601051 PMCID: PMC6826485 DOI: 10.3390/genes10100784] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Revised: 10/02/2019] [Accepted: 10/03/2019] [Indexed: 12/27/2022] Open
Abstract
microRNAs (miRNAs) have been established as critical regulators of the pathogenesis of diabetes mellitus (DM), and diabetes microvascular complications (DMCs). However, manually curated databases for miRNAs, and DM (including DMCs) association studies, have yet to be established. Here, we constructed a user-friendly database, “miR2Diabetes,” equipped with a graphical web interface for simple browsing or searching manually curated annotations. The annotations in our database cover 14 DM and DMC phenotypes, involving 156 miRNAs, by browsing diverse sample origins (e.g., blood, kidney, liver, and other tissues). Additionally, we provide miRNA annotations for disease-model organisms (including rats and mice), of DM and DMCs, for the purpose of improving knowledge of the biological complexity of these pathologies. We assert that our database will be a comprehensive resource for miRNA biomarker studies, as well as for prioritizing miRNAs for functional validation, in DM and DMCs, with likely extension to other diseases.
Collapse
Affiliation(s)
- Sungjin Park
- College of Medicine, Gachon University, Incheon 21565, Korea.
- Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon 21565, Korea.
| | - SeongRyeol Moon
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon 21565, Korea.
| | - Kiyoung Lee
- Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea.
- Department of Internal Medicine, Gachon University School of Medicine, Incheon 21565, Korea.
| | - Ie Byung Park
- Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea.
- Department of Internal Medicine, Gachon University School of Medicine, Incheon 21565, Korea.
| | - Dae Ho Lee
- Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea.
- Department of Internal Medicine, Gachon University School of Medicine, Incheon 21565, Korea.
| | - Seungyoon Nam
- College of Medicine, Gachon University, Incheon 21565, Korea.
- Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon 21565, Korea.
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon 21565, Korea.
- Department of Life Sciences, Gachon University, Seongnam 13120, Korea.
| |
Collapse
|
22
|
Moon S, Balch C, Park S, Lee J, Sung J, Nam S. Systematic Inspection of the Clinical Relevance of TP53 Missense Mutations in Gastric Cancer. IEEE/ACM Trans Comput Biol Bioinform 2019; 16:1693-1701. [PMID: 29994072 DOI: 10.1109/tcbb.2018.2814049] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The "guardian of the genome," TP53, is one of the most frequently mutated genes of all cancers. Despite the important biological roles of TP53, the clinical relevance of TP53 mutations, in gastric cancer (GC), remains largely unknown. Here, we systematically assessed clinical relevance, in terms of TP53 mutation positions, finding substantial variability. Thus, we hypothesized that the position of the TP53 mutation might affect clinical outcomes in GC. We systematically inspected missense mutations in TP53, from a TCGA (The Cancer Genome Atlas) GC dataset in UCSC Xena repository. Specifically, we examined five aspects of each mutational position: (1) the whole gene body; (2) known hot-spots; (3) the DNA-binding domain; (4) the secondary structure of the domain; and (5) individual mutation positions. We then analyzed the clinical outcomes for each aspect. These results showed that, in terms of secondary structure, patients with mutations in turn regions showed poor prognosis, compared to those with mutations in beta strand regions (log rank ${\text{p}}= {{0.043}}$p=0.043). Also, in terms of individual mutation positions, patients having mutations at R248 showed poorer survival than other patients having mutations at different TP53 positions (log rank ${\text{p}}= {{0.035}}$p=0.035).
Collapse
|
23
|
Girod S, Mittermiller P, Bidwell S, Thieringer F, Cornelius C, Trickey A, Kontio R, Bader M, Goetz P, Johns D, Smolka W, Mesimaki K, Moon S, Probst F, Qiiao J, Snall J, Wilkmann T, Girod S. The comprehensive AO CMF classification system for mandibular fractures: a multicenter validation study. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Howell SJ, Waters S, Twelves C, Joffe J, Moon S, Bale C, Venkitaraman R, Bezecny P, Casbard A, Wilhelm-Benartzi C, Carucci M, Butler R, Alchami F, Jones R. Abstract PD1-07: Withdrawn. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd1-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Citation Format: Howell SJ, Waters S, Twelves C, Joffe J, Moon S, Bale C, Venkitaraman R, Bezecny P, Casbard A, Wilhelm-Benartzi C, Carucci M, Butler R, Alchami F, Jones R. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD1-07.
Collapse
Affiliation(s)
- SJ Howell
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - S Waters
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - C Twelves
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - J Joffe
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - S Moon
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - C Bale
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - R Venkitaraman
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - P Bezecny
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - A Casbard
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - C Wilhelm-Benartzi
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - M Carucci
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - R Butler
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - F Alchami
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| | - R Jones
- University of Manchester, Manchester, United Kingdom; The Christie NHS Foundation Trust, Manchester, United Kingdom; Velindre Cancer Centre, Cardiff, United Kingdom; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom; Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom; University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom; Betsi Cadwaladr University Health Board, Bangor, United Kingdom; The Ipswich Hospital NHS Trust, Ipswich, United Kingdom; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; All Wales Laboratory Genetics Service, University Hospital of Wales, Cardiff, United Kingdom; University Hospital of Wales, Cardiff, United Kingdom; Cardiff University, Cardiff, United Kingdom
| |
Collapse
|
25
|
Yun S, Lee K, Park Y, Moon S, Lee H, Choe G, Lee K. Clinicopathological and prognostic significance of programmed death ligand 1 expression in Korean melanoma patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy439.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
26
|
Park J, Moon S, Cho H, Kim D, Yoon Y, Cho Y. 350 Effect of Team-Based CPR Training for Emergency Medical Services Providers on Out-of-Hospital Return of Spontaneous Circulation in Cardiac Arrest Patients. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
|
28
|
KIM C, Moon J, Kang B, Moon S. Serum testosterone and free testosterone levels may be negatively correlated with mitochondrial function of granulosa cells in women with polycystic ovary syndrome. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
29
|
Park M, Moon S, Cho M. Optimization of adipose tissue-derived mesenchymal stem cells by metformin in a murine model of osteoarthritis. Cytotherapy 2018. [DOI: 10.1016/j.jcyt.2018.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Park S, Moon S, Lee K, Park IB, Lee DH, Nam S. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis. Cell Physiol Biochem 2018; 46:1331-1340. [PMID: 29689545 DOI: 10.1159/000489148] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 02/27/2018] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND/AIMS Diabetic nephropathy (DN), a major diabetic microvascular complication, has a long and growing list of biomarkers, including microRNA biomarkers, which have not been consistent across preclinical and clinical studies. This meta-analysis aims to identify significant blood- and urine-incident microRNAs as diagnostic/prognostic biomarker candidates for DN. METHODS PubMed, Web of Science, and Cochrane Library were searched from their earliest records through 12th Dec 2016. Relevant publications for the meta-analysis included (1) human participants; (2) microRNAs in blood and urine; (3) DN studies; and (4) English language. Four reviewers, including two physicians, independently and blindly extracted published data regarding microRNA profiles in blood and/or urine from subjects with diabetic nephropathy. A random-effect model was used to pool the data. Statistical associations between diabetic nephropathy and urinary or blood microRNA expression levels were assessed. RESULTS Fourteen out of 327 studies (n=2,747 patients) were selected. Blood or urinary microRNA expression data of diabetic nephropathy were pooled for this analysis. The hsa-miR-126 family was significantly (OR: 0.57; 95% CI: 0.44-0.74; p-value < 0.0001) downregulated in blood from patients with diabetic kidney disease, while its urinary level was upregulated (OR: 2931.12; 95% CI: 9.96-862623.21; p-value = 0.0059). The hsa-miR-770 family microRNA were significantly (OR: 10.24; 95% CI: 2.37-44.25; p-value = 0.0018) upregulated in both blood and urine from patients with diabetic nephropathy. CONCLUSIONS Our meta-analysis suggests that hsa-miR-126 and hsa-miR-770 family microRNA may have important diagnostic and pathogenetic implications for DN, which warrants further systematic clinical studies.
Collapse
Affiliation(s)
- Sungjin Park
- Department of Genome Medicine and Science, Gachon University College of Medicine, Incheon, Republic of Korea.,Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, Republic of Korea
| | - SeongRyeol Moon
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, Republic of Korea
| | - Kiyoung Lee
- Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.,Department of Internal Medicine, Gachon University College of Medicine, Incheon, Republic of Korea
| | - Ie Byung Park
- Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.,Department of Internal Medicine, Gachon University College of Medicine, Incheon, Republic of Korea
| | - Dae Ho Lee
- Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, Republic of Korea.,Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.,Department of Internal Medicine, Gachon University College of Medicine, Incheon, Republic of Korea
| | - Seungyoon Nam
- Department of Genome Medicine and Science, Gachon University College of Medicine, Incheon, Republic of Korea.,Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, Republic of Korea.,Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon, Republic of Korea.,Department of Life Sciences, Gachon University, Seongnam, Republic of Korea
| |
Collapse
|
31
|
Lee W, Moon S. Is consumer choice in health care good for society from an efficiency perspective. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx186.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- W Lee
- Myeongho-myeon Health Subcenter, Ansan, South Korea
| | - S Moon
- Myeongho-myeon Health Subcenter, Ansan, South Korea
| |
Collapse
|
32
|
Moon S. 292 Study on the seasonal changes in average daily gain, feed value, forage productivity, and grazing intensity in native pasture grazed by Korean native goat (Capra hircus coreanae). J Anim Sci 2017. [DOI: 10.2527/asasann.2017.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Oh M, Moon S, Kim MS. 267 Inspection for fecal contamination on chicken carcass using handheld imaging device. J Anim Sci 2017. [DOI: 10.2527/asasann.2017.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Moon S. 599 Energy requirements for maintenance of growing Korean indigenous goats (Capra hircus coreanae). J Anim Sci 2017. [DOI: 10.2527/asasann.2017.599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Song T, Moon S, Park B, Hwang Y, Song E, Kim H, Hong G. FEASIBILITY OF VIRTUAL REALITY EXPERIENCE OF NATURE AS A NURSING INTERVENTION. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- T. Song
- Hanyang University, Seoul, Korea (the Republic of)
| | - S. Moon
- Hanyang University, Seoul, Korea (the Republic of)
| | - B. Park
- Hanyang University, Seoul, Korea (the Republic of)
| | - Y. Hwang
- Hanyang University, Seoul, Korea (the Republic of)
| | - E. Song
- Hanyang University, Seoul, Korea (the Republic of)
| | - H. Kim
- Hanyang University, Seoul, Korea (the Republic of)
| | - G. Hong
- Hanyang University, Seoul, Korea (the Republic of)
| |
Collapse
|
36
|
Moon S, Hong G. PREDICTORS OF CHEWING DIFFICULTIES AMONG COMMUNITY-DWELLING OLDER ADULTS IN KOREA. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- S. Moon
- Nursing, Hanyang university, Hwaseong-si, Kyeong-gi do, Korea (the Republic of)
| | - G. Hong
- Nursing, Hanyang university, Hwaseong-si, Kyeong-gi do, Korea (the Republic of)
| |
Collapse
|
37
|
Kim E, Kong S, Lee J, Moon S, Oh J, Sung K, Kim S, Park S, Shim J, Yoon S, Moon J, Park J, Kim S, Lee S, Huh Y, Chang J, Kang S. P08.27 Isolation of tumor mesenchymal stem-like cells from high grade gliomas according to the weight of fresh specimens. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox036.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Lei P, Ayton S, Appukuttan AT, Moon S, Duce JA, Volitakis I, Cherny R, Wood SJ, Greenough M, Berger G, Pantelis C, McGorry P, Yung A, Finkelstein DI, Bush AI. Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry 2017; 22:396-406. [PMID: 27400857 DOI: 10.1038/mp.2016.96] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2016] [Revised: 04/25/2016] [Accepted: 05/09/2016] [Indexed: 02/05/2023]
Abstract
Lithium is a first-line therapy for bipolar affective disorder. However, various adverse effects, including a Parkinson-like hand tremor, often limit its use. The understanding of the neurobiological basis of these side effects is still very limited. Nigral iron elevation is also a feature of Parkinsonian degeneration that may be related to soluble tau reduction. We found that magnetic resonance imaging T2 relaxation time changes in subjects commenced on lithium therapy were consistent with iron elevation. In mice, lithium treatment lowers brain tau levels and increases nigral and cortical iron elevation that is closely associated with neurodegeneration, cognitive loss and parkinsonian features. In neuronal cultures lithium attenuates iron efflux by lowering tau protein that traffics amyloid precursor protein to facilitate iron efflux. Thus, tau- and amyloid protein precursor-knockout mice were protected against lithium-induced iron elevation and neurotoxicity. These findings challenge the appropriateness of lithium as a potential treatment for disorders where brain iron is elevated (for example, Alzheimer's disease), and may explain lithium-associated motor symptoms in susceptible patients.
Collapse
Affiliation(s)
- P Lei
- Department of Neurology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Sichuan, China.,Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - S Ayton
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - A T Appukuttan
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - S Moon
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - J A Duce
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.,Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, West Yorkshire, UK
| | - I Volitakis
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - R Cherny
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - S J Wood
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Parkville, VIC, Australia.,School of Psychology, University of Birmingham, Birmingham, UK
| | - M Greenough
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - G Berger
- ORYGEN Research Centre, University of Melbourne and Melbourne Health, Parkville, VIC, Australia.,Department of Child and Adolescent Psychiatry, University of Zürich, Zurich, Switzerland
| | - C Pantelis
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.,Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Parkville, VIC, Australia.,Centre for Neural Engineering, Department of Electrical and Electronic Engineering, University of Melbourne, Parkville, VIC, Australia
| | - P McGorry
- ORYGEN Research Centre, University of Melbourne and Melbourne Health, Parkville, VIC, Australia
| | - A Yung
- Institute of Brain, Behaviour and Mental Health, University of Manchester and Greater Manchester West NHS Mental Health Trust, Manchester, UK
| | - D I Finkelstein
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - A I Bush
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
| |
Collapse
|
39
|
Adam A, Spencer K, Moon S, Jacub I. Smartphone, Smart Surgeon, what about a 'Smart Logbook'? S AFR J SURG 2016; 54:36-42. [PMID: 28240502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGROUND Mobile phone applications (Apps) have become a vital assistant to medical personnel in today's technologically advanced era. The utility of Apps with case logbook capabilities has not yet been explored. OBJECTIVE To assess and evaluate all currently available surgical and procedural case logbook Apps. METHOD A comprehensive search was conducted in April 2015 on the Android Play Store, iTunes (Apple App Store, iOS), and BlackBerry World for surgical and/or procedural logbooks. The search terms'surgical logbook', 'logbook', 'procedure logbook' and 'surgical log' were used. Apps which could not be utilized as a surgical/procedural logbook were excluded. Each App was individually assessed and rated using preset criteria, by the unit consultant, registrars, and medical officer. RESULTS In total, 2 740 Apps were assessed. After applying our exclusion criteria, only 16 Apps were relevant, and 11 suitable for critical review. Data sizes ranged from 510Kb to 12.2Mb. Costing of the Apps ranged from ZAR 0.00 to ZAR 105.32. The overall study scores revealed the following top five rated Apps: Surgical Logbook by Surgilog; Surgeon Logbook Pro; Surgery Notebook, Surgical Logbook, and Universal Logbook. CONCLUSION The current mobile Apps available are efficient in replacing traditional case logbooks. The use of the 'Smart Logbook' may become common practice in the life of the modern-day surgeon.
Collapse
Affiliation(s)
- A Adam
- Department of Urology, Helen Joseph Hospital
- Department of Paediatric Urology, Rahima Moosa Mother & Child (Coronation) Hospital
- Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South Africa
| | - K Spencer
- Department of Urology, Helen Joseph Hospital
- Department of Paediatric Urology, Rahima Moosa Mother & Child (Coronation) Hospital
- Division of Urology, Department of Surgery, University of the Witwatersrand, Johannesburg, South Africa
| | - S Moon
- Developer, MIP Holdings (Pty) Ltd
| | - I Jacub
- Developer, MIP Holdings (Pty) Ltd
| |
Collapse
|
40
|
Moon S, Yoon M, Chung W, Chung M, Kim D. SU-F-T-17: A Feasibility Study for the Transit Dosimetry with a Glass Dosimeter in Brachytherapy. Med Phys 2016. [DOI: 10.1118/1.4956151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
41
|
Kim J, Kim Y, Kim J, Kim J, Choi C, Lim J, Moon S, Yu K, Park Y, Chang S. 703 Anti-aging potential of gypenosides fraction obtained from naturally grown Gynostemma pentaphyllum in Ulleungdo Island and its 7 new gypenosides. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Moon S, Yoon M, Chung M, Chung W, Kim D. PO-0897: Comparison of hippocampus sparing extent according to the tilt of a patient head during WBRT. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32147-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Chung S, Park J, Choi M, Yang J, Park T, Kim M, Lee N, Moon S. Is mirtazapine really effective in the treatment of Korean elderly depressed patients with insomnia after previous antidepressant failure?: An open-label, multicenter study. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.1515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
St Clair J, Moon S, Holbrook WS, Perron JT, Riebe CS, Martel SJ, Carr B, Harman C, Singha K, Richter DD. Geophysical imaging reveals topographic stress control of bedrock weathering. Science 2015; 350:534-8. [PMID: 26516279 DOI: 10.1126/science.aab2210] [Citation(s) in RCA: 206] [Impact Index Per Article: 22.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Bedrock fracture systems facilitate weathering, allowing fresh mineral surfaces to interact with corrosive waters and biota from Earth's surface, while simultaneously promoting drainage of chemically equilibrated fluids. We show that topographic perturbations to regional stress fields explain bedrock fracture distributions, as revealed by seismic velocity and electrical resistivity surveys from three landscapes. The base of the fracture-rich zone mirrors surface topography where the ratio of horizontal compressive tectonic stresses to near-surface gravitational stresses is relatively large, and it parallels the surface topography where the ratio is relatively small. Three-dimensional stress calculations predict these results, suggesting that tectonic stresses interact with topography to influence bedrock disaggregation, groundwater flow, chemical weathering, and the depth of the "critical zone" in which many biogeochemical processes occur.
Collapse
Affiliation(s)
- J St Clair
- Department of Geology and Geophysics and Wyoming Center for Environmental Hydrology and Geophysics, University of Wyoming, Laramie, WY 82071, USA.
| | - S Moon
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | - W S Holbrook
- Department of Geology and Geophysics and Wyoming Center for Environmental Hydrology and Geophysics, University of Wyoming, Laramie, WY 82071, USA
| | - J T Perron
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - C S Riebe
- Department of Geology and Geophysics and Wyoming Center for Environmental Hydrology and Geophysics, University of Wyoming, Laramie, WY 82071, USA
| | - S J Martel
- Department of Geology and Geophysics, University of Hawaii, Honolulu, HI 96822, USA
| | - B Carr
- Department of Geology and Geophysics and Wyoming Center for Environmental Hydrology and Geophysics, University of Wyoming, Laramie, WY 82071, USA
| | - C Harman
- Department of Geography and Environmental Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA
| | - K Singha
- Hydrologic Science and Engineering Program, Colorado School of Mines, Golden, CO 80401, USA
| | - D deB Richter
- Nicholas School of the Environment, Duke University, Durham, NC 27708, USA
| |
Collapse
|
45
|
Moon S, Kim D, Chung W, Yoon M. SU-E-T-449: Hippocampal Sparing Radiotherapy Using Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy. Med Phys 2015. [DOI: 10.1118/1.4924811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
46
|
Lee D, Ghafoor K, Moon S, Kim S, Kim S, Chun H, Park J. Phenolic compounds and antioxidant properties of high hydrostatic pressure and conventionally treated ginseng (Panax ginseng) products. Quality Assurance and Safety of Crops & Foods 2015. [DOI: 10.3920/qas2014.0416] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- D. Lee
- Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
- Nutrex Technology Co., 670 Daewangpangyo-ro, Bundang-gu, Seongnam 138-962, Republic of Korea
| | - K. Ghafoor
- Department of Food Science and Nutrition, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia
| | - S. Moon
- Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
| | - S.H. Kim
- Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
| | - S. Kim
- Nutrex Technology Co., 670 Daewangpangyo-ro, Bundang-gu, Seongnam 138-962, Republic of Korea
| | - H. Chun
- R&D Center, Danone Pulmuone Co., Anam-dong 5-ga, Seongbuk-gu, Seoul 136-710, Republic of Korea
| | - J. Park
- Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
| |
Collapse
|
47
|
Kim Y, Song J, Wu H, Ahn Y, Keum K, Lee C, Cho K, Moon S, Chung W, Oh Y. PO-069: The role of neoadjuvant chemotherapy in the treatment of nasopharyngeal carcinoma. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)34829-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Kim K, Moon S, Kim Y, Kim T, Cho K, Han J, Lee Y, Yun T, Kim H, Lee J. Treatment Outcomes of Limited-Stage Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation Therapy: A Comparative Analysis of Different Radiation Dose Fractionation Schedules in a Single Institution. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
49
|
Cho K, Min C, Jung J, Lee S, Lee S, Huh H, Cho S, Shim J, Chang K, Kim W, Yong Ho K, Moon S, Kim E, Yeo S, Kwon S. Dosimetric Evaluation Using MVCT Images for Adapted Plan-Dose Monitoring in Tomotherapy. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
50
|
So H, Kim H, Oh G, Yang S, Lee S, Moon S, Kwon K, Park R. 720: Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)50633-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|